These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35259244)

  • 1. Balsalazide Exposure During the Development of Fertilizing Sperm May Be Associated With Offspring Birth Defects.
    Wensink MJ; Streett SE; Damkier P; Lindahl-Jacobsen R; Kjeldsen J; Eisenberg ML
    Inflamm Bowel Dis; 2022 Oct; 28(10):1607-1609. PubMed ID: 35259244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of birth defects is not associated with semen parameters or mode of conception in offspring of men visiting a reproductive health clinic.
    Pastuszak AW; Herati AS; Eisenberg ML; Cengiz C; Langlois PH; Kohn TP; Lamb DJ; Lipshultz LI
    Hum Reprod; 2019 Apr; 34(4):733-739. PubMed ID: 30753581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of balsalazide therapy in the treatment of inflammatory bowel disease.
    Baker DE
    Rev Gastroenterol Disord; 2005; 5(3):135-41. PubMed ID: 16127348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group.
    Green JR; Lobo AJ; Holdsworth CD; Leicester RJ; Gibson JA; Kerr GD; Hodgson HJ; Parkins KJ; Taylor MD
    Gastroenterology; 1998 Jan; 114(1):15-22. PubMed ID: 9428213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring : A Nationwide Cohort Study.
    Wensink MJ; Lu Y; Tian L; Shaw GM; Rizzi S; Jensen TK; Mathiesen ER; Skakkebæk NE; Lindahl-Jacobsen R; Eisenberg ML
    Ann Intern Med; 2022 May; 175(5):665-673. PubMed ID: 35344380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
    Lowry PW; Franklin CL; Weaver AL; Szumlanski CL; Mays DC; Loftus EV; Tremaine WJ; Lipsky JJ; Weinshilboum RM; Sandborn WJ
    Gut; 2001 Nov; 49(5):656-64. PubMed ID: 11600468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case-control study of paternal smoking and birth defects.
    Zhang J; Savitz DA; Schwingl PJ; Cai WW
    Int J Epidemiol; 1992 Apr; 21(2):273-8. PubMed ID: 1428480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balsalazide in treating colonic diseases.
    Tursi A
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1555-63. PubMed ID: 19708827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety evaluation of the offspring conceived by assisted reproductive technology with donor's semen].
    Liang M; Zhang B; Sun W; Xu P; Zhang Z; Yang XY; Cao XR; Hu HL; Li Z
    Zhonghua Nan Ke Xue; 2011 Mar; 17(3):237-41. PubMed ID: 21485545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods and concepts in detecting abnormal reproductive outcomes of paternal origin.
    Wyrobek AJ
    Reprod Toxicol; 1993; 7 Suppl 1():3-16. PubMed ID: 8400638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
    Kruis W; Schreiber S; Theuer D; Brandes JW; Schütz E; Howaldt S; Krakamp B; Hämling J; Mönnikes H; Koop I; Stolte M; Pallant D; Ewald U
    Gut; 2001 Dec; 49(6):783-9. PubMed ID: 11709512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.
    Muijsers RB; Goa KL
    Drugs; 2002; 62(11):1689-705. PubMed ID: 12109930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of childhood mortality in family members of men with poor semen quality.
    Hanson HA; Mayer EN; Anderson RE; Aston KI; Carrell DT; Berger J; Lowrance WT; Smith KR; Hotaling JM
    Hum Reprod; 2017 Jan; 32(1):239-247. PubMed ID: 27927843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balsalazide.
    Prakash A; Spencer CM
    Drugs; 1998 Jul; 56(1):83-9; discussion 90. PubMed ID: 9664201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balsalazide-induced myocarditis.
    Robertson E; Austin D; Jamieson N; Hogg KJ
    Int J Cardiol; 2008 Nov; 130(3):e121-2. PubMed ID: 17889383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal with balsalazide of infertility caused by sulphsalazine.
    McIntyre PB; Lennard-Jones JE
    Br Med J (Clin Res Ed); 1984 Jun; 288(6431):1652-3. PubMed ID: 6144351
    [No Abstract]   [Full Text] [Related]  

  • 20. Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group.
    Green JR; Gibson JA; Kerr GD; Swarbrick ET; Lobo AJ; Holdsworth CD; Crowe JP; Schofield KJ; Taylor MD
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1207-16. PubMed ID: 9882028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.